Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors
- PMID: 1462099
- DOI: 10.1002/ssu.2980080507
Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors
Abstract
Growth factors (GFs) are a class of proteins that bind to specific cell surface receptors (GF-Rs), inducing a variety of responses including mitosis, in susceptible target cells. Abnormal production, expression, and/or function of GFs or GF-Rs can result in unregulated growth, the hallmark of malignant transformation. This chapter reviews those GFs/GF-Rs that have been linked to human bladder cancer. It focuses particularly on one [epidermal growth factor (EGF), which is excreted in urine in high concentrations] and its possible role in the development and growth of urothelial malignancy. Potential clinical applications in diagnosis, staging, prevention, and treatment are discussed.
Similar articles
-
Epidermal growth factor and its receptor: markers of--and targets for--chemoprevention of bladder cancer.J Cell Biochem Suppl. 1992;16I:56-62. doi: 10.1002/jcb.240501312. J Cell Biochem Suppl. 1992. PMID: 1305689 Review.
-
Recovery of epidermal growth factor in voided urine of patients with bladder cancer.Urology. 1994 Oct;44(4):502-6. doi: 10.1016/s0090-4295(94)80047-2. Urology. 1994. PMID: 7941190
-
Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.J Urol. 2000 May;163(5):1440-4. J Urol. 2000. PMID: 10751853
-
Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology.Gastroenterology. 1995 Feb;108(2):564-80. doi: 10.1016/0016-5085(95)90087-x. Gastroenterology. 1995. PMID: 7835600 Review. No abstract available.
-
Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.Cancer Res. 1990 Apr 15;50(8):2530-7. Cancer Res. 1990. PMID: 1690599
Cited by
-
Temporally and spatially controllable gene expression and knockout in mouse urothelium.Am J Physiol Renal Physiol. 2010 Aug;299(2):F387-95. doi: 10.1152/ajprenal.00185.2010. Epub 2010 Apr 28. Am J Physiol Renal Physiol. 2010. PMID: 20427471 Free PMC article.
-
Enhanced gene expression of transforming growth factor-alpha and c-met in rat urinary bladder cancer.Urol Res. 1996;24(1):55-60. doi: 10.1007/BF00296735. Urol Res. 1996. PMID: 8966843
-
Biology of urothelial tumorigenesis: insights from genetically engineered mice.Cancer Metastasis Rev. 2009 Dec;28(3-4):281-90. doi: 10.1007/s10555-009-9189-4. Cancer Metastasis Rev. 2009. PMID: 20012171 Free PMC article. Review.
-
Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.Cancer Res. 2009 Dec 15;69(24):9413-21. doi: 10.1158/0008-5472.CAN-09-2158. Cancer Res. 2009. PMID: 19951992 Free PMC article.
-
Targeted therapies in the management of metastatic bladder cancer.Biologics. 2007 Dec;1(4):393-406. Biologics. 2007. PMID: 19707309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical